CONTINUOUS GLUCOSE MONITORING DEVICES MARKET ANALYSIS

Regional Analysis

Global Continuous Glucose Monitoring Devices Market: Regional Insights

Based on geography, the global continuous glucose monitoring devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period owing to the increasing cases of diabetes, growing geriatric population, increasing demand for continuous glucose monitoring devices, and increasing adoption of alternate and novel devices in the region. For instance, in February 2022, the Food and Drug Administration (FDA) approved Senseonics’ new continuous glucose monitor (CGM), called the Eversense E3 System, for diabetes with a sensor that can last for up to 6 months. According to the company, the device is the longest lasting CGM approved in the United States and the world.

Asia Pacific is also expected to witness robust growth in the global continuous glucose monitoring devices market owing to the increasing prevalence of diabetes, growing geriatric population, high demand for continuous glucose monitoring devices, and increasing awareness among people in the region. For instance, according to the World Health Organization (WHO), in India, more than 77 Billion people above the age of 18 years are suffering from diabetes (type 2) and nearly 25 Billion are prediabetes (at a higher risk of developing diabetes in near future). While. 50% are unaware of their diabetic status which leads to health complications if not detected and treated early.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa